DYN Dyne Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 29, 2026
$15,20
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,4352-Wochen-Tief
$27,3152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.52B
P/E
-4.4
EPS
$-3.47
Ihre Abzeichen
52W-Spanne
$12–$27
Analystenbewertung
BUY
Kursziel
$36
P/E
-4.4
ROE
-57.8%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DYN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$15.20
Marktkapitalisierung (MRQ)
$2.52B
P/E
-4.4
EPS
$-3.47
ROE
-57.8%
52W-Spanne
$12–$27
DYN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-3.472021-12-31 → 2025-12-31
Freier Cashflow$-405M2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DYN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -4.45-Jahres-Durchschnitt ≈-4.7 | ≈-4.7 | · | · | |
| K/B (MRQ) | 3.65-Jahres-Durchschnitt ≈4.1 | ≈4.1 | 4.6 | Überbewertet | |
| Kurs / FCF (TTM) | -5.25-Jahres-Durchschnitt ≈-5.9 | ≈-5.9 | · | · | |
| Kurs / Cashflow (TTM) | -5.35-Jahres-Durchschnitt ≈-6.0 | ≈-6.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.65-Jahres-Durchschnitt ≈4.1 | ≈4.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DYN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -47.5%5-Jahres-Durchschnitt ≈-61.2% | ≈-61.2% | -31.7% | Schwach | |
| ROE | -57.8%5-Jahres-Durchschnitt ≈-80.9% | ≈-80.9% | -20.6% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DYN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 12.05-Jahres-Durchschnitt ≈12.6 | ≈12.6 | 10.1 | Starke Liquidität | |
| Quick Ratio | 17.65-Jahres-Durchschnitt ≈8.7 | ≈8.7 | 8.3 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-7.1%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 27, 2026 | $-1.08 | $-0.76 | -42.4% |
| 31. März 2026 | $-0.73 | $-0.78 | 6.5% | |
| 31. Dezember 2025 | $-0.76 | $-0.78 | 2.3% | |
| 30. September 2025 | $-0.76 | $-0.85 | 10.1% | |
| 30. Juni 2025 | $-0.97 | $-0.96 | -0.60% | |
| 31. März 2025 | $-1.05 | $-0.89 | -18.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $398M | $281M | $211M | $143M | $121M | $45M | $11M | |
| SG&A Expense | $70M | $62M | $31M | $28M | $29M | $13M | $3M | |
| Operating Expenses | $468M | $344M | $242M | $171M | $150M | $59M | $14M | |
| Operating Income | $-468M | $-344M | $-242M | $-171M | $-150M | $-59M | $-14M | |
| Other Non-op | $22M | $26M | $6M | $3M | $734.0K | $-790.0K | $-1M | |
| Income Tax | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | $-15M | |
| EPS (Basic) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EPS (Diluted) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EBITDA | $-466M | $-342M | $-240M | $-169M | $-149M | $-58M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $893M | $435M | $122M | $172M | $201M | $301M | $15M | |
| Prepaid Expense | $16M | $17M | $6M | $10M | $6M | $4M | $127.0K | |
| Current Assets | $1.13B | $659M | $129M | $266M | $382M | $349M | $15M | |
| PP&E (Net) | $24M | $5M | $5M | $6M | $5M | $2M | $1M | |
| PP&E (Gross) | $33M | $12M | $10M | $10M | $7M | $3M | $2M | |
| Accum. Depreciation | $9M | $7M | $5M | $4M | $2M | $995.0K | $295.0K | |
| Other Non-current Assets | · | · | · | · | · | · | $191.0K | |
| Total Assets | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Accounts Payable | $8M | $7M | $23M | $5M | $4M | $3M | $1M | |
| Current Liabilities | $51M | $42M | $51M | $28M | $29M | $11M | $2M | |
| Capital Leases | $15M | $19M | $23M | $26M | $29M | $0 | · | |
| Total Liabilities | $215M | $61M | $74M | $54M | $57M | $11M | $2M | |
| Long-term Debt | $149M | $0 | · | · | · | · | · | |
| Common Stock | $16.0K | $10.0K | $6.0K | $6.0K | $6.0K | $5.0K | $1.0K | |
| Paid-in Capital | $2.37B | $1.58B | $724M | $650M | $597M | $422M | $6M | |
| Retained Earnings | $-1.40B | $-950M | $-633M | $-397M | $-228M | $-79M | $-20M | |
| AOCI | $475.0K | $6.0K | $0 | $-571.0K | $-269.0K | $-27.0K | · | |
| Stockholders' Equity | $972M | $630M | $91M | $252M | $368M | $342M | $14M | |
| Liabilities + Equity | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Shares Outstanding | 164,950,540 | 102,318,629 | 61,468,743 | 55,636,505 | 51,569,381 | 45,076,574 | 2,586,535 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | $700.0K | $271.0K | |
| Stock-based Comp | $46M | $46M | $20M | $15M | $18M | $7M | $26.0K | |
| Other Non-cash | $-5M | $-22M | $26M | $-2M | $11M | $6M | · | |
| Operating Cash Flow | $-403M | $-292M | $-188M | $-154M | $-120M | $-47M | $-12M | |
| CapEx | $2M | $2M | $729.0K | $3M | $4M | $1M | $2M | |
| Investing Cash Flow | $-29M | $-204M | $83M | $87M | $-138M | $-46M | $-2M | |
| Debt Issued | $148M | $0 | $0 | · | · | $10M | · | |
| Net Debt Issued | $148M | · | · | · | · | $10M | · | |
| Stock Issued | $141M | $98M | $52M | $37M | · | · | · | |
| Net Stock Activity | $141M | $98M | · | · | · | · | · | |
| Financing Cash Flow | $890M | $810M | $54M | $37M | $158M | $381M | $20M | |
| Net Change in Cash | $458M | $313M | $-51M | $-29M | $-100M | $289M | $7M | |
| Free Cash Flow | $-405M | $-295M | $-189M | $-157M | $-123M | $-48M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -47.5% | -74.1% | -100.1% | -45.9% | -38.3% | -32.1% | · | |
| ROE | -57.8% | -47.5% | -193.9% | -67.0% | -38.2% | -16.8% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 | 31.8 | · | |
| Quick Ratio | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 | 27.4 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.89 | $6.16 | $1.49 | $4.54 | $7.14 | $7.60 | · | |
| Cash / Share | $5.42 | $4.26 | $1.98 | $3.09 | $3.89 | $6.67 | · | |
| EPS (TTM) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | · | |
| Market Cap | $3.23B | $2.41B | $818M | $645M | $613M | $947M | · | |
| P/E | -5.6 | -7.0 | -3.4 | -3.6 | -4.1 | · | · | |
| P/B | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Tangible Book | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Cash Flow | -8.0 | -8.2 | -4.3 | -4.2 | -5.1 | -20.4 | · | |
| P / FCF | -8.0 | -8.2 | -4.3 | -4.1 | -5.0 | -19.9 | · | |
| Earnings Yield | -17.7% | -14.3% | -29.7% | -27.9% | -24.6% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $152M | $101M | $95M | $97M | $99M | $106M | $82M | $93M | $62M | $45M | $55M | $59M | $38M | $35M | $47M | $28M | |
| SG&A Expense | $29M | $24M | $21M | $17M | $17M | $16M | $15M | $13M | $10M | $25M | $7M | $8M | $8M | $8M | $6M | $8M | |
| Operating Expenses | $182M | $125M | $116M | $114M | $116M | $122M | $97M | $106M | $72M | $69M | $62M | $67M | $45M | $42M | $53M | $36M | |
| Operating Income | $-182M | $-125M | $-116M | $-114M | $-116M | $-122M | $-97M | $-106M | $-72M | $-69M | $-62M | $-67M | $-45M | $-42M | $-53M | $-36M | |
| Interest Expense | · | · | · | $3M | $94.0K | · | · | $0 | · | · | · | · | · | · | · | · | |
| Other Non-op | $3M | $4M | $4M | $6M | $5M | $7M | $8M | $9M | $7M | $4M | $2M | $2M | $1M | $894.0K | $451.0K | $200.0K | |
| Net Income | $-179M | $-121M | $-112M | $-108M | $-111M | $-115M | $-90M | $-97M | $-65M | $-66M | $-60M | $-65M | $-44M | $-41M | $-52M | $-36M | |
| EPS (Basic) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EPS (Diluted) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EBITDA | $-181M | $-125M | · | $-113M | $-115M | $-122M | · | $-105M | $-72M | $-69M | $-62M | $-66M | $-45M | $-42M | $-52M | $-35M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $753M | $893M | $574M | $485M | $472M | $435M | $532M | $608M | $272M | $130M | $168M | $181M | $145M | $136M | $148M | |
| Prepaid Expense | $39M | $49M | $16M | $14M | $14M | $12M | $17M | $13M | $13M | $35M | $10M | $5M | $11M | $10M | $6M | $21M | |
| Current Assets | $938M | $1.02B | $1.13B | $806M | $698M | $690M | $659M | $736M | $792M | $488M | $168M | $213M | $249M | $258M | $298M | $344M | |
| PP&E (Net) | $25M | $24M | $24M | $24M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $6M | |
| PP&E (Gross) | $34M | $33M | $33M | $32M | $13M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | $10M | $9M | $8M | $8M | |
| Accum. Depreciation | $10M | $9M | $9M | $8M | $8M | $7M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Total Assets | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Accounts Payable | $12M | $11M | $8M | $12M | $14M | $7M | $7M | $6M | $2M | $7M | $4M | $3M | $9M | $919.0K | $7M | $5M | |
| Current Liabilities | $78M | $51M | $51M | $60M | $41M | $34M | $42M | $43M | $30M | $22M | $30M | $20M | $22M | $23M | $26M | $23M | |
| Capital Leases | $15M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $22M | $24M | $24M | $25M | $27M | $27M | $28M | |
| Total Liabilities | $292M | $215M | $215M | $175M | $158M | $52M | $61M | $63M | $51M | $44M | $53M | $45M | $47M | $50M | $53M | $51M | |
| Long-term Debt | $199M | $149M | $149M | $99M | $99M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $16.0K | $14.0K | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $2.40B | $2.38B | $2.37B | $1.98B | $1.75B | $1.73B | $1.58B | $1.57B | $1.54B | $1.18B | $718M | $713M | $683M | $608M | $605M | $601M | |
| Retained Earnings | $-1.70B | $-1.52B | $-1.40B | $-1.28B | $-1.18B | $-1.07B | $-950M | $-860M | $-763M | $-698M | $-566M | $-506M | $-441M | $-358M | $-316M | $-264M | |
| AOCI | $-353.0K | $-137.0K | $475.0K | $496.0K | $252.0K | $241.0K | $6.0K | $478.0K | $-240.0K | $-132.0K | $-13.0K | $-56.0K | $-203.0K | $-983.0K | $-1M | $-930.0K | |
| Stockholders' Equity | $702M | $865M | $972M | $692M | $571M | $669M | $630M | $706M | $775M | $478M | $152M | $207M | $242M | $250M | $287M | $336M | |
| Liabilities + Equity | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Shares Outstanding | 165,670,880 | 165,201,329 | 164,950,540 | 142,613,248 | 114,338,610 | 113,633,782 | 102,318,629 | 101,753,378 | 100,119,518 | 87,089,649 | 61,322,283 | 61,013,986 | 58,305,480 | 51,906,773 | 51,734,361 | 51,649,423 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $550.0K | $547.0K | $500.0K | $500.0K | $502.0K | $487.0K | $400.0K | $400.0K | $386.0K | $400.0K | $400.0K | $412.0K | $400.0K | $500.0K | $425.0K | |
| Stock-based Comp | $15M | $13M | $11M | $11M | $11M | $13M | $10M | $9M | $7M | $20M | $5M | $5M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | $-38M | · | · | · | $-4M | · | · | · | $-33M | · | · | $-8M | · | · | $-20M | |
| Operating Cash Flow | $-130M | $-145M | $-112M | $-91M | $-95M | $-106M | $-84M | $-75M | $-55M | $-79M | $-51M | $-56M | $-47M | $-43M | $-31M | $-51M | |
| CapEx | $2M | $221.0K | $484.0K | $395.0K | $60.0K | $981.0K | $1M | $253.0K | $857.0K | $191.0K | $167.0K | $250.0K | $230.0K | $886.0K | $261.0K | $1M | |
| Investing Cash Flow | $-5M | $-2M | $982.0K | $-38M | $7M | $1M | $-16M | $-19M | $11M | $-180M | $13M | $17M | $27M | $52M | $18M | $-2M | |
| Debt Issued | · | · | $49M | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $141M | $0 | $0 | $24M | $74M | $0 | $24M | $28M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $141M | · | · | · | $74M | · | · | · | · | · | · | |
| Financing Cash Flow | $58M | $7M | $431M | $217M | $101M | $141M | $4M | $18M | $380M | $408M | $454.0K | $25M | $29M | $70.0K | $99.0K | $18.0K | |
| Net Change in Cash | $-77M | $-140M | $320M | $89M | $13M | $37M | $-97M | $-76M | $336M | $150M | $-37M | $-14M | $9M | $9M | $-12M | $-53M | |
| Free Cash Flow | · | $-145M | · | · | · | $-107M | · | · | · | $-79M | · | · | $-47M | · | · | $-52M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.7% | -13.4% | · | -13.2% | -14.3% | -18.6% | · | -19.9% | -12.1% | -16.2% | -23.8% | -21.9% | -13.1% | -10.8% | -13.0% | -8.1% | |
| ROE | -28.0% | -15.8% | · | -15.5% | -16.5% | -20.1% | · | -22.7% | -13.3% | -18.2% | -30.0% | -26.3% | -15.3% | -12.5% | -14.1% | -8.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 19.9 | · | 13.5 | 16.8 | 20.4 | · | 17.0 | 26.6 | 21.8 | 5.7 | 10.5 | 11.5 | 11.1 | 11.6 | 14.8 | |
| Quick Ratio | 8.7 | 14.7 | · | 9.6 | 11.7 | 13.9 | · | 12.3 | 20.4 | 12.2 | 4.4 | 8.3 | 8.4 | 6.2 | 5.3 | 6.4 | |
| Interest Coverage | · | · | · | -39.2 | -1231.8 | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.24 | $5.24 | · | $4.85 | $5.00 | $5.89 | · | $6.93 | $7.74 | $5.49 | $2.48 | $3.39 | $4.15 | $4.81 | $5.55 | $6.51 | |
| Cash / Share | $4.08 | $4.56 | · | $4.02 | $4.24 | $4.16 | · | $5.23 | $6.07 | $3.12 | $2.12 | $2.75 | $3.11 | $2.79 | $2.63 | $2.86 | |
| EPS (TTM) | $-3.26 | $-3.15 | · | $-3.68 | $-3.88 | $-3.61 | · | $-3.57 | $-3.60 | $-3.98 | $-3.58 | $-3.39 | $-3.32 | $-3.51 | $-3.54 | $-3.11 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-519M | $-452M | · | $-424M | $-413M | $-367M | · | $-295M | $-258M | $-257M | $-208M | $-189M | $-177M | $-181M | $-182M | $-160M | |
| Market Cap | $3.68B | $3.00B | · | $1.80B | $1.09B | $1.19B | · | $3.65B | $3.53B | $2.47B | $549M | $686M | $672M | $659M | $355M | $498M | |
| P/E | -6.8 | -5.8 | · | -3.4 | -2.5 | -2.9 | · | -10.1 | -9.8 | -7.1 | -2.5 | -3.3 | -3.5 | -3.6 | -1.9 | -3.1 | |
| P/B | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Tangible Book | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Cash Flow | · | -20.7 | · | · | · | -11.2 | · | · | · | -31.5 | · | · | -14.3 | · | · | -9.8 | |
| Earnings Yield | -14.7% | -17.4% | · | -29.1% | -40.8% | -34.5% | · | -9.9% | -10.2% | -14.0% | -40.0% | -30.1% | -28.8% | -27.6% | -51.5% | -32.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-446M | $-317M | $-236M | $-168M | $-149M |
| Verwässerte EPS | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 |
| Quick Ratio | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-405M | $-295M | $-189M | $-157M | $-123M |
Institutionelle Eigentümer (13F) 259 Einreicher · $3.7B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
259
Gehaltener Wert
$3.7B
Neue Positionen
46
Geschlossene Positionen
27
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (+4 vs. Vorquartal) | 27 (-14 vs. Vorquartal) | 90 (-12 vs. Vorquartal) | 76 (+14 vs. Vorquartal) | -9.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $275.500.169 | 12.404.330 | 7,51% | Aktien |
| FMR LLC | $248.907.468 | 11.207.000 | 6,79% | Aktien |
| JANUS HENDERSON GROUP PLC | $247.426.927 | 13.647.376 | 6,75% | Aktien |
| VANGUARD GROUP INC | $219.376.451 | 11.215.565 | 5,98% | Aktien |
| STATE STREET CORP | $165.648.021 | 7.458.263 | 4,52% | Aktien |
| Orbis Allan Gray Ltd | $155.615.298 | 7.006.542 | 4,24% | Aktien |
| Atlas Venture Life Science Advisors, LLC | $151.030.199 | 6.800.099 | 4,12% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $140.166.621 | 6.310.969 | 3,82% | Aktien |
| TCG Crossover Management, LLC | $102.502.348 | 4.615.144 | 2,80% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $89.915.586 | 4.048.428 | 2,45% | Aktien |
| FCPM III SERVICES B.V. | $85.469.766 | 3.848.256 | 2,33% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $83.158.757 | 3.743.427 | 2,27% | Aktien |
| Vestal Point Capital, LP | $74.958.750 | 3.375.000 | 2,04% | Aktien |
| ORBIMED ADVISORS LLC | $71.864.542 | 3.235.684 | 1,96% | Aktien |
| Frazier Life Sciences Management, L.P. | $70.029.951 | 3.153.082 | 1,91% | Aktien |
| ARMISTICE CAPITAL, LLC | $68.567.289 | 3.087.226 | 1,87% | Aktien |
| JPMORGAN CHASE & CO | $67.154.494 | 3.151.656 | 1,83% | Aktien |
| PERCEPTIVE ADVISORS LLC | $59.727.909 | 2.689.235 | 1,63% | Aktien |
| Logos Global Management LP | $56.635.500 | 2.550.000 | 1,54% | Aktien |
| BANK OF AMERICA CORP /DE/ | $49.603.770 | 2.233.398 | 1,35% | Aktien |
| Venrock Adviser, LLC | $48.282.608 | 2.173.913 | 1,32% | Aktien |
| GOLDMAN SACHS GROUP INC | $47.911.301 | 2.157.195 | 1,31% | Aktien |
| Siren, L.L.C. | $47.287.866 | 2.129.125 | 1,29% | Aktien |
| FRANKLIN RESOURCES INC | $45.104.481 | 2.030.819 | 1,23% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $43.221.836 | 1.946.479 | 1,18% | Aktien |
| MPM BIOIMPACT LLC | $42.689.686 | 1.922.093 | 1,16% | Aktien |
| SAMLYN CAPITAL, LLC | $38.972.065 | 1.754.708 | 1,06% | Aktien |
| Sofinnova Investments, Inc. | $36.832.709 | 1.658.384 | 1,00% | Aktien |
| Palo Alto Investors LP | $36.591.441 | 1.647.521 | 1,00% | Aktien |
| Vivo Capital, LLC | $34.591.320 | 1.557.466 | 0,94% | Aktien |
| Aberdeen Group plc | $34.190.829 | 1.539.434 | 0,93% | Aktien |
| Deep Track Capital, LP | $33.315.000 | 1.500.000 | 0,91% | Aktien |
| MARSHALL WACE, LLP | $33.068.847 | 1.488.917 | 0,90% | Aktien |
| Polar Capital Holdings Plc | $28.580.072 | 1.286.811 | 0,78% | Aktien |
| NORTHERN TRUST CORP | $28.386.180 | 1.278.081 | 0,77% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26.700.929 | 1.202.203 | 0,73% | Aktien |
| CITADEL ADVISORS LLC | $25.407.307 | 1.143.958 | 0,69% | Aktien |
| Saturn V Capital Management LP | $23.486.920 | 1.057.493 | 0,64% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $21.964.557 | 988.949 | 0,60% | Aktien |
| NOVO HOLDINGS A/S | $21.330.351 | 960.394 | 0,58% | Aktien |
| Rock Springs Capital Management LP | $20.925.240 | 942.154 | 0,57% | Aktien |
| BRAIDWELL LP | $20.468.692 | 921.598 | 0,56% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $19.414.605 | 874.138 | 0,53% | Aktien |
| BAKER BROS. ADVISORS LP | $18.066.702 | 813.449 | 0,49% | Aktien |
| Fiera Capital Corp | $17.545.656 | 789.989 | 0,48% | Aktien |
| MORGAN STANLEY | $16.573.116 | 746.200 | 0,45% | Aktien |
| Artisan Partners Limited Partnership | $14.653.847 | 659.786 | 0,40% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $12.800.733 | 576.350 | 0,35% | Aktien |
| TD Asset Management Inc | $12.173.568 | 548.112 | 0,33% | Aktien |
| ALGERT GLOBAL LLC | $11.244.323 | 506.273 | 0,31% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×2 Einreichungen | 10. Februar 2023 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 26 Insider · 11 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John Cox | CEO & President | 8. September 2026 S | 357.507 | 0 | 6 | $-443.688 |
| Joshua T Brumm | CEO & President | 11. März 2024 M | 537.998 | 0 | 0 | $0 |
| Erick Lucera | Chief Financial Officer | 13. August 2026 S | 119.766 | 0 | 4 | $-228.675 |
| Susanna Gatti High | Chief Operating Officer | 18. September 2024 S | 131.636 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | Chief Commercial Officer | 8. September 2026 S | 152.897 | 0 | 7 | $-43.380 |
| Douglas Kerr | Chief Medical Officer | 8. September 2026 S | 162.564 | 0 | 7 | $-233.116 |
| Oxana Beskrovnaya | Chief Scientific Officer | 11. März 2025 S | 195.840 | 0 | 0 | $0 |
| Richard William Scalzo | SVP, Head of Finance & Admin. | 11. März 2025 S | 122.330 | 0 | 0 | $0 |
| Wildon Farwell | Chief Medical Officer | 19. August 2024 S | 143.222 | 0 | 0 | $0 |
| Jonathan Mcneill | Chief Business Officer | 19. August 2024 S | 132.106 | 0 | 0 | $0 |
| Romesh Subramanian | Chief Scientific Officer | 16. September 2020 A | 566.249 | 0 | 0 | $0 |
| Jason P Rhodes | Direktor | 14. August 2026 S | 428.946 | 0 | 79 | $-129.095.799 |
| Dirk Kersten | Direktor | 27. Juli 2026 S | 3.586.796 | 0 | 19 | $-38.570.974 |
| Barry E Greene | Direktor | 22. Juni 2026 A | · | 0 | 0 | $0 |
| Carlo Incerti | Direktor | 5. Juni 2026 A | 0 | 0 | 0 | $0 |
| Catherine Stehman-Breen | Direktor | 5. Juni 2026 A | 115.713 | 0 | 0 | $0 |
| David Charles Lubner | Direktor | 5. Juni 2026 A | 0 | 0 | 0 | $0 |
| Brian S Posner | Direktor | 5. Juni 2026 A | 24.500 | 7 | 0 | $274.840 |
| Edward Hurwitz | Direktor | 5. Juni 2026 A | 91.081 | 0 | 0 | $0 |
| Vikram Karnani | Direktor | 22. Dezember 2025 A | · | 0 | 0 | $0 |
| Lawrence Otto Klein | Direktor | 5. Juli 2022 A | 10.725 | 0 | 0 | $0 |
| Atlas Venture Fund XI, L.P. | 10%-Eigentümer | 13. Juli 2021 J | 7.326.117 | 0 | 0 | $0 |
| CureDuchenne Ventures, LLC | 10%-Eigentümer | 21. September 2020 C | 602.972 | 0 | 0 | $0 |
| Forbion Capital Fund IV Cooperatief U.A. | 10%-Eigentümer | 21. September 2020 C | 6.131.079 | 0 | 0 | $0 |
| Logos Global Management LP | 10%-Eigentümer | 21. September 2020 C | 1.504.392 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10%-Eigentümer | 21. September 2020 C | 1.608.785 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 41 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 2,55% | 10.352 SH | 11. September 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,93% | 17.087 NS | 31. Juli 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,82% | 2.968 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,72% | 140.706 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,23% | 3.298 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,20% | 1.142.515 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,20% | 1.922 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 13.206 SH | 2. Oktober 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 41.341 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,13% | 4.624 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 77.375 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,12% | 72.365 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 3.869.303 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 784.894 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,08% | 478.626 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 37.091 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,06% | 494.945 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 50.849 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 83.903 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 65.771 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 47.064 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 81.555 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.689.620 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 347.244 SH | 19. August 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 1.020.875 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 8.555 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 1.607.020 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,02% | 3.800 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 12.166 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 217.916 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 14.680 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 37.664 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 199.795 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 31.685 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 39.299 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.473.029 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.370 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 928.355 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 7.751 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 12.245 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 33.057 SH | 11. September 2026 | Täglich |
DYN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 21 Analysten
KAUF
Median-Ziel
$37.00
+143,4%
7 33,3%
Starker Kauf
12 57,1%
Kauf
2 9,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
15 Analysten · 2026-10-03Mittelwert-Ziel $36.00 +136,8%
Jetzt
Aktueller Preis $15.20
Tief$10.00
Mittelwert$36.00
Hoch$50.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 29, 2026